| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,204 | 4,505 | 3,387 | 10,834 | | Cost of Revenue | 855 | 1,922 | 2,252 | 7,010 | | | Gross Profit | 4,349 | 2,583 | 1,135 | 3,824 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,956 | 5,704 | 5,003 | 2,868 | | Non Recurring | 251 | (121) |
-
| 29,570 | | Others | 1,288 | 1,592 | 1,656 | 3,189 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,018) | (4,592) | (5,524) | (31,803) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 984 | 3,042 | 329 | (2,541) | | Earnings Before Interest And Taxes | (162) | (1,550) | (5,195) | (34,344) | | Interest Expense | 610 | 871 | 1,078 | 1,460 | | Income Before Tax | (772) | (2,421) | (6,273) | (35,804) | | Income Tax Expense | (233) | (691) | (78) | 2,677 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (539) | (1,730) | (6,195) | (38,481) | | | Non-recurring Events | | Discontinued Operations | (11,919) | 4,612 | (4,681) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,458) | 2,882 | (10,876) | (38,481) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,458) | $2,882 | ($10,876) | ($38,481) |
|
0.31% Nasdaq 
0.05%
Income Statement
